Hugh Burrill
Follow
Get notifications in MyBN when activity occurs.
Hugh Burrill
Non-Executive Director / IDT Australia
Hugh Burrill provides consulting services in pharmaceutical management, product development, regulatory affairs and intellectual property.
Mr Burrill was the corporate vice president of global pharma research & development at Hospira Inc where he was part of overall pipeline portfolio management, and research and development of specialty pharmaceuticals. Prior to that, he held senior international roles within Hospira Inc and the original Mayne Pharma.
Mr Burrill was the corporate vice president of global pharma research & development at Hospira Inc where he was part of overall pipeline portfolio management, and research and development of specialty pharmaceuticals. Prior to that, he held senior international roles within Hospira Inc and the original Mayne Pharma.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 137th | IDT Australia | 114% | -5% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | IDT Australia | $14.0m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, IDT Australia | 03 Nov 2020 |
